HCA Healthcare, Inc. (NYSE:HCA) Stock Position Lessened by MAI Capital Management

MAI Capital Management decreased its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 28.3% in the 3rd quarter, HoldingsChannel reports. The firm owned 1,773 shares of the company’s stock after selling 699 shares during the quarter. MAI Capital Management’s holdings in HCA Healthcare were worth $721,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently modified their holdings of the business. Acadian Asset Management LLC boosted its stake in HCA Healthcare by 115.5% during the first quarter. Acadian Asset Management LLC now owns 3,372 shares of the company’s stock valued at $1,123,000 after buying an additional 1,807 shares in the last quarter. CreativeOne Wealth LLC bought a new position in HCA Healthcare during the first quarter valued at about $231,000. Advisors Asset Management Inc. lifted its holdings in shares of HCA Healthcare by 117.5% during the first quarter. Advisors Asset Management Inc. now owns 2,543 shares of the company’s stock valued at $848,000 after purchasing an additional 1,374 shares during the last quarter. 1832 Asset Management L.P. purchased a new stake in shares of HCA Healthcare during the first quarter valued at $26,672,000. Finally, LRI Investments LLC purchased a new stake in shares of HCA Healthcare during the first quarter valued at $69,000. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Stock Performance

Shares of NYSE HCA opened at $324.92 on Friday. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12. The firm has a market cap of $82.30 billion, a price-to-earnings ratio of 14.59, a P/E/G ratio of 1.29 and a beta of 1.68. The business’s 50-day simple moving average is $379.40 and its 200-day simple moving average is $358.05. HCA Healthcare, Inc. has a 52 week low of $245.84 and a 52 week high of $417.14.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be issued a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.81%. The ex-dividend date is Friday, December 13th. HCA Healthcare’s dividend payout ratio is 11.85%.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on HCA. Truist Financial upped their target price on HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a report on Monday, August 19th. Wells Fargo & Company increased their price objective on HCA Healthcare from $395.00 to $400.00 and gave the stock an “equal weight” rating in a research note on Wednesday, November 6th. Barclays reduced their price objective on HCA Healthcare from $396.00 to $392.00 and set an “overweight” rating for the company in a research note on Friday, November 8th. TD Cowen reduced their price objective on HCA Healthcare from $450.00 to $440.00 and set a “buy” rating for the company in a research note on Monday, October 28th. Finally, Raymond James downgraded HCA Healthcare from an “outperform” rating to a “market perform” rating in a research note on Friday. Six research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and two have given a strong buy rating to the company. According to MarketBeat, HCA Healthcare has a consensus rating of “Moderate Buy” and a consensus price target of $385.00.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, SVP Phillip G. Billington sold 3,897 shares of the firm’s stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total value of $1,363,950.00. Following the completion of the sale, the senior vice president now owns 52,702 shares in the company, valued at approximately $18,445,700. This trade represents a 6.89 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Erol R. Akdamar sold 2,900 shares of the firm’s stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total value of $1,023,700.00. Following the completion of the sale, the insider now owns 6,843 shares of the company’s stock, valued at $2,415,579. This represents a 29.76 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 15,155 shares of company stock valued at $5,608,990 in the last 90 days. 1.60% of the stock is currently owned by insiders.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.